Tus-Pharmaceutical Group Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 9.97% vs -15.43% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 58.28% vs -96.39% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "71.70",
          "val2": "65.20",
          "chgp": "9.97%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-7.20",
          "val2": "-7.00",
          "chgp": "-2.86%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.50",
          "val2": "0.90",
          "chgp": "-44.44%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-6.80",
          "val2": "-16.30",
          "chgp": "58.28%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-99.80%",
          "val2": "-236.00%",
          "chgp": "13.62%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is -1.64% vs -15.06% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 60.61% vs -610.84% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "335.10",
          "val2": "340.70",
          "chgp": "-1.64%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1.00",
          "val2": "-23.10",
          "chgp": "104.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "3.50",
          "val2": "3.70",
          "chgp": "-5.41%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-26.40",
          "val2": "-119.60",
          "chgp": "77.93%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-50.10",
          "val2": "-127.20",
          "chgp": "60.61%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-95.10%",
          "val2": "-153.60%",
          "chgp": "5.85%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY

Mar'26

Mar'25

Change(%)

Net Sales

71.70

65.20

9.97%

Operating Profit (PBDIT) excl Other Income

-7.20

-7.00

-2.86%

Interest

0.50

0.90

-44.44%

Exceptional Items

0.00

0.00

Consolidate Net Profit

-6.80

-16.30

58.28%

Operating Profit Margin (Excl OI)

-99.80%

-236.00%

13.62%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Mar 2026 is 9.97% vs -15.43% in Mar 2025

Consolidated Net Profit

YoY Growth in quarter ended Mar 2026 is 58.28% vs -96.39% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

335.10

340.70

-1.64%

Operating Profit (PBDIT) excl Other Income

1.00

-23.10

104.33%

Interest

3.50

3.70

-5.41%

Exceptional Items

-26.40

-119.60

77.93%

Consolidate Net Profit

-50.10

-127.20

60.61%

Operating Profit Margin (Excl OI)

-95.10%

-153.60%

5.85%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is -1.64% vs -15.06% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 60.61% vs -610.84% in Dec 2024

All Annual Results